Barclays’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $665K | Buy |
321,424
+138,878
| +76% | +$287K | ﹤0.01% | 2887 |
|
|
2025
Q1 | $402K | Sell |
182,546
-58,800
| -24% | -$129K | ﹤0.01% | 2956 |
|
|
2024
Q4 | $370K | Buy |
241,346
+22,891
| +10% | +$35.1K | ﹤0.01% | 3221 |
|
|
2024
Q3 | $434K | Buy |
218,455
+50,109
| +30% | +$99.6K | ﹤0.01% | 3073 |
|
|
2024
Q2 | $590K | Buy |
168,346
+31,887
| +23% | +$112K | ﹤0.01% | 2438 |
|
|
2024
Q1 | $378K | Sell |
136,459
-42,295
| -24% | -$117K | ﹤0.01% | 2998 |
|
|
2023
Q4 | $303K | Buy |
178,754
+124,044
| +227% | +$210K | ﹤0.01% | 3298 |
|
|
2023
Q3 | $56K | Sell |
54,710
-2,523
| -4% | -$2.58K | ﹤0.01% | 3551 |
|
|
2023
Q2 | $65K | Sell |
57,233
-41,700
| -42% | -$47.4K | ﹤0.01% | 3560 |
|
|
2023
Q1 | $149K | Buy |
98,933
+24,314
| +33% | +$36.6K | ﹤0.01% | 3316 |
|
|
2022
Q4 | $187K | Sell |
74,619
-351,735
| -82% | -$881K | ﹤0.01% | 3123 |
|
|
2022
Q3 | $1.8M | Buy |
426,354
+288,093
| +208% | +$1.22M | ﹤0.01% | 1730 |
|
|
2022
Q2 | $385K | Sell |
138,261
-1,050
| -0.8% | -$2.92K | ﹤0.01% | 2752 |
|
|
2022
Q1 | $797K | Sell |
139,311
-2,553
| -2% | -$14.6K | ﹤0.01% | 2474 |
|
|
2021
Q4 | $1.3M | Buy |
141,864
+55,786
| +65% | +$509K | ﹤0.01% | 2051 |
|
|
2021
Q3 | $921K | Buy |
86,078
+43,159
| +101% | +$462K | ﹤0.01% | 2300 |
|
|
2021
Q2 | $666K | Sell |
42,919
-95,707
| -69% | -$1.49M | ﹤0.01% | 2323 |
|
|
2021
Q1 | $2.25M | Buy |
138,626
+70,775
| +104% | +$1.15M | ﹤0.01% | 1770 |
|
|
2020
Q4 | $1.44M | Sell |
67,851
-3,485
| -5% | -$73.8K | ﹤0.01% | 1781 |
|
|
2020
Q3 | $1.06M | Buy |
71,336
+2,542
| +4% | +$37.7K | ﹤0.01% | 1886 |
|
|
2020
Q2 | $1.01M | Buy |
68,794
+25,337
| +58% | +$373K | ﹤0.01% | 1915 |
|
|
2020
Q1 | $511K | Sell |
43,457
-44,813
| -51% | -$527K | ﹤0.01% | 2111 |
|
|
2019
Q4 | $2.07M | Sell |
88,270
-6,184
| -7% | -$145K | ﹤0.01% | 1860 |
|
|
2019
Q3 | $1.75M | Buy |
94,454
+44,722
| +90% | +$828K | ﹤0.01% | 1868 |
|
|
2019
Q2 | $924K | Buy |
49,732
+11,053
| +29% | +$205K | ﹤0.01% | 2385 |
|
|
2019
Q1 | $945K | Buy |
38,679
+12,686
| +49% | +$310K | ﹤0.01% | 2184 |
|
|
2018
Q4 | $674K | Sell |
25,993
-35,566
| -58% | -$922K | ﹤0.01% | 2079 |
|
|
2018
Q3 | $1.95M | Buy |
61,559
+53,320
| +647% | +$1.69M | ﹤0.01% | 1803 |
|
|
2018
Q2 | $320K | Sell |
8,239
-22,159
| -73% | -$861K | ﹤0.01% | 2516 |
|
|
2018
Q1 | $839K | Buy |
30,398
+18,792
| +162% | +$519K | ﹤0.01% | 1942 |
|
|
2017
Q4 | $210K | Sell |
11,606
-17,185
| -60% | -$311K | ﹤0.01% | 2630 |
|
|
2017
Q3 | $465K | Buy |
28,791
+23,426
| +437% | +$378K | ﹤0.01% | 1958 |
|
|
2017
Q2 | $74K | Buy |
5,365
+3,456
| +181% | +$47.7K | ﹤0.01% | 2883 |
|
|
2017
Q1 | $29K | Sell |
1,909
-10,429
| -85% | -$158K | ﹤0.01% | 3267 |
|
|
2016
Q4 | $162K | Buy |
12,338
+11,715
| +1,880% | +$154K | ﹤0.01% | 2399 |
|
|
2016
Q3 | $10K | Sell |
623
-30,282
| -98% | -$486K | ﹤0.01% | 3258 |
|
|
2016
Q2 | $558K | Buy |
30,905
+22,199
| +255% | +$401K | ﹤0.01% | 1710 |
|
|
2016
Q1 | $157K | Buy |
8,706
+3,818
| +78% | +$68.9K | ﹤0.01% | 2162 |
|
|
2015
Q4 | $127K | Buy |
4,888
+4,520
| +1,228% | +$117K | ﹤0.01% | 2219 |
|
|
2015
Q3 | $9K | Sell |
368
-153
| -29% | -$3.74K | ﹤0.01% | 3099 |
|
|
2015
Q2 | $17K | Sell |
521
-183
| -26% | -$5.97K | ﹤0.01% | 3047 |
|
|
2015
Q1 | $11K | Sell |
704
-1,188
| -63% | -$18.6K | ﹤0.01% | 3354 |
|
|
2014
Q4 | $19K | Buy |
1,892
+1,127
| +147% | +$11.3K | ﹤0.01% | 3447 |
|
|
2014
Q3 | $6K | Sell |
765
-160
| -17% | -$1.26K | ﹤0.01% | 3896 |
|
|
2014
Q2 | $11K | Buy |
+925
| New | +$11K | ﹤0.01% | 3616 |
|